UAL
56
2
LMT
47
7
ILMN
41
-3
WAT
54
2
FE
55
5
DNB
50
-4
USB
44
-3
STI
17
3
PEG
76
5
LB
38
-7
MU
34
3
BAC
41
-6
WEC
45
2
MS
64
7
SIG
57
-3
DOV
64
-5
CNX
80
4
HOG
50
6
UPS
55
-6
HSY
40
2
UAL
56
2
LMT
47
7
ILMN
41
-3
WAT
54
2
FE
55
5
DNB
50
-4
USB
44
-3
STI
17
3
PEG
76
5
LB
38
-7
MU
34
3
BAC
41
-6
WEC
45
2
MS
64
7
SIG
57
-3
DOV
64
-5
CNX
80
4
HOG
50
6
UPS
55
-6
HSY
40
2
Financhill
Back

Banco do Brasil SA BB Brasil Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
58

BDORY
Banco do Brasil SA BB Brasil

Last Price:
4.91
Seasonality Move:
-0.61%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
58
Banco do Brasil SA BB Brasil (BDORY) is a Buy

Is Banco do Brasil SA BB Brasil a Buy, Sell or Hold?

  • The current Banco do Brasil SA BB Brasil [BDORY] share price is $4.91. The Score for BDORY is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • BDORY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

BDORY Stock Price Chart

What is Banco do Brasil SA BB Brasil's stock price today?

  • The Banco do Brasil SA BB Brasil share price today is $4.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDORY is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

BDORY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 40.02 Sell
Chaikin Money Flow: -121903 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.05 - 5.27) Sell
Bollinger Bands (100): (4.84 - 5.3) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

BDORY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.15 Sell
20-day SMA: 5.13 Sell
50-day SMA: 5.01 Sell
200-day SMA: 5.35 Sell
8-day EMA: 5.12 Sell
20-day EMA: 5.12 Sell
50-day EMA: 5.07 Sell
200-day EMA: 5.13 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Banco do Brasil SA BB Brasil Earnings Growth & BDORY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Banco do Brasil SA BB Brasil Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):